Cancer Drugs | Online pharmaceuticals | Treatment for Cancer

BORTEZOMIB INJECTION Bortezomib  belongs to anti-cancer medicine, which is available in the form of lyophilized powder.  Bortezomib  is a first beneficial proteasome inhibitor; proteasome is a cellular structure that breaks the proteins. INDICATION Bortezomib  is majorly used to treat Multiple myeloma. Mantle cell lymphoma. DOSAGE AND ADMINISTRATION Generally,  Bortezomib  is in lyophilized powder form; which is reconstituted by using 0.9% sodium chloride (NS) Bortezomib should be reconstituted in 3.5ml NS The route of administration is IV bolus Intrathecal not use for administration. IN ADULTS MANTLE CELL LYMPHOMA The usual dose of Bortezomib for untreated mantle cell lymphoma is;  1.3mg/m2 of  Bortezomib  administered as IV bolus given as two times weekly by combining with rituximab, cyclophosphamide, doxorubicin, and tablet prednisolone for two weeks (the day I, IV, VIII & XI) followed by 10 day rest period (day II through 21)  In R

EVEROLIMUS DESCRIPTION  Everolimus  belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor).  Everolimus  is an immunosuppressive macrolide. EVEROLIMUS USED FOR Breast cancer  The patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with  Everolimus .  Everolimus  is used in the advanced stage of breast cancer. Neuroendocrine tumors  Everolimus involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer Patient treating with  Everolimus  after the failure of treatment with Sunitinib or Sorafenib.  Everolimus  also used in the condition of Heart, liver, kidney transplantation, Waldenstrom macroglobulinemia, Other carcinoid tumors Brand: Evertor Strength: 10mg Ingredient: Everolimus Company Name: Biocon Tab Count: 10 Tablets MECHANISM OF ACTION Everolimus  is the prohibition o